Literature DB >> 20665484

Head and neck cancer: proteomic advances and biomarker achievements.

Taia Maria Berto Rezende1, Mirna de Souza Freire, Octávio Luiz Franco.   

Abstract

Tumors of the head and neck comprise an important neoplasia group, the incidence of which is increasing in many parts of the world. Recent advances in diagnostic and therapeutic techniques for these lesions have yielded novel molecular targets, uncovered signal pathway dominance, and advanced early cancer detection. Proteomics is a powerful tool for investigating the distribution of proteins and small molecules within biological systems through the analysis of different types of samples. The proteomic profiles of different types of cancer have been studied, and this has provided remarkable advances in cancer understanding. This review covers recent advances for head and neck cancer; it encompasses the risk factors, pathogenesis, proteomic tools that can help in understanding cancer, and new proteomic findings in this type of cancer.
Copyright © 2010 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665484     DOI: 10.1002/cncr.25245

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

1.  Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.

Authors:  Pratima Tripathi; Pachiyappan Kamarajan; Bagganahalli S Somashekar; Neil MacKinnon; Arul M Chinnaiyan; Yvonne L Kapila; Thekkelnaycke M Rajendiran; Ayyalusamy Ramamoorthy
Journal:  Int J Biochem Cell Biol       Date:  2012-06-26       Impact factor: 5.085

2.  MALDI-imaging segmentation is a powerful tool for spatial functional proteomic analysis of human larynx carcinoma.

Authors:  Theodore Alexandrov; Michael Becker; Orlando Guntinas-Lichius; Günther Ernst; Ferdinand von Eggeling
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-06       Impact factor: 4.553

3.  Expression of stefin A is of prognostic significance in squamous cell carcinoma of the head and neck.

Authors:  Aleksandar Aničin; Nina Gale; Lojze Smid; Janko Kos; Primož Strojan
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-02       Impact factor: 2.503

4.  Immunohistochemical expression levels of p53 and eIF4E markers in histologically negative surgical margins, and their association with the clinical outcome of patients with head and neck squamous cell carcinoma.

Authors:  Jagtar Singh; Rama Jayaraj; Siddhartha Baxi; Mariana Mileva; John Skinner; Navneet K Dhand; Mahiban Thomas
Journal:  Mol Clin Oncol       Date:  2015-12-01

5.  Wnt/β-catenin/Slug pathway contributes to tumor invasion and lymph node metastasis in head and neck squamous cell carcinoma.

Authors:  Jung Hwa Moon; Sang Hyuk Lee; Young Chang Lim
Journal:  Clin Exp Metastasis       Date:  2021-02-25       Impact factor: 5.150

Review 6.  Molecular and cellular processes underlying the hallmarks of head and neck cancer.

Authors:  Jonathan M Bernstein; Clare R Bernstein; Catharine M L West; Jarrod J Homer
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-23       Impact factor: 2.503

7.  BRCA1 and MDM2 as independent blood-based biomarkers of head and neck cancer.

Authors:  Aditi Bhowmik; Sambuddha Das; Abhinandan Bhattacharjee; Biswadeep Choudhury; Momota Naiding; Sankar Kumar Ghosh; Yashmin Choudhury
Journal:  Tumour Biol       Date:  2016-10-06

8.  The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics.

Authors:  Qihui Wang; Pan Gao; Xiaoyi Wang; Yixiang Duan
Journal:  Sci Rep       Date:  2014-10-30       Impact factor: 4.379

9.  Identification of human tissue kallikrein 6 as a potential marker of laryngeal cancer based on the relevant secretory/releasing protein database.

Authors:  Ying Zhang; Zaixing Zhang; Lei Yang; Bin Xu; Weihua Li; Pingzhang Tang; Zongmin Zhang; Naijun Han; Yanning Gao; Shujun Cheng; Ting Xiao
Journal:  Dis Markers       Date:  2014-02-11       Impact factor: 3.434

10.  Clinical application of computed tomography-guided (125)I seed interstitial implantation for head and neck cancer patients with unmanageable cervical lymph node metastases.

Authors:  Hai Huang; Shaonian Xu; Fusheng Li; Zhenguang Du; Liang Wang
Journal:  Eur J Med Res       Date:  2016-04-27       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.